Vice President, Global Compensation
Regeneron Pharmaceuticals
Summary
The Vice President, Global Compensation is an enterprise leader and steward of Regeneron's global compensation strategy. This role integrates job architecture, base pay, incentives, equity, and executive compensation into a cohesive, scalable framework, driving the attraction, retention, motivation, and recognition of 16,000+ employees across 14 countries.
Job description
Strategic Leadership
- Partner with the SVP, Total Rewards and CHRO to define and evolve the global compensation philosophy in support of growth and a high-performance culture
- Anticipate current and future business needs and lead the analysis, design, and recommendations for evolving plans and programs
- Lead the evolution of compensation technology, applying automation and AI-enabled tools to improve the speed, quality, and insight of pay decisions
- Lead compensation due diligence and integration for M&A
Executive Collaboration and Influence
- Build a strategic relationship with the Compensation Committee and its independent consultant
- Advise senior executives, HR Business Partners, and Centers of Excellence on complex pay decisions, organizational change, and talent strategy
- Work with Legal, Finance, Accounting, and other leaders to govern and steward all plans and programs
Operational Excellence
- Own seamless execution of the annual global compensation cycle (base, bonus, equity)
- Oversee compensation practices across all geographies, balancing global consistency with local market, legal, and works council requirements
- Own job architecture, leveling frameworks, salary structures, and market pricing
- Partner with Talent Planning & Capability on career frameworks and skills readiness
- Design an operating model that integrates regional teams, shared services, and centers of excellence
- Drive compensation analytics and scenario modeling to inform hiring, retention, and workforce planning
Team Leadership
- Build and lead an integrated global team spanning compensation design, executive compensation, sales incentives, analytics, and systems
- Lead the team through change associated with compensation strategy, technology modernization, process evolution, and organizational growth
- Work with the US and International Benefits teams to integrate total rewards thinking, service delivery, and employee engagement
- Foster a culture of innovation with an automation-first mindset and data-driven decision-making
Requirements
- Bachelor's degree in Human Resources, Business Administration, Finance, or a related discipline
- 20+ years of progressive experience in compensation, total rewards, or human resources
- 10+ years leading a large global team at a publicly traded company of comparable scale and complexity
- Demonstrated expertise in broad-based compensation, executive pay, equity plan design, and public company governance
- Strong working knowledge of relevant laws, regulations, and tax and accounting rules
- Advanced financial modeling, analytical, and executive communication skills
- Proven record of advising and influencing executive leadership
- Ability to manage multiple high-priority workstreams concurrently with sound judgment and minimal guidance
- High degree of integrity and discretion with sensitive information
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension/Retirement Benefits
- 401(k) Matching
- Health & Wellness Programs
- Fitness Centers
- Medical, Dental & Vision
- Life & Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.